jueves, 20 de noviembre de 2025
Nirsevimab for Babies: How the New RSV Protection Works
https://www.news-medical.net/health/Nirsevimab-for-Babies-How-the-New-RSV-Protection-Works.aspx
Emerging clinical evidence shows that nirsevimab can extend powerful, single-dose RSV protection to all infants, reshaping how we safeguard babies during their most vulnerable months.
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario